The UK’s CBD market has flourished despite the impact of COVID-19.
The rest of the world has steamed ahead with the legalisation of medical and recreational cannabis creating multibillion-dollar industries, while the UK has watched quietly from the sidelines. However, the UK’s CBD industry is now flourishing, creating ample opportunity for entrepreneurs and investors alike.
Professor Mike Barnes, of Medical Cannabis Clinics and Maple Tree Consulting, speaks to Health Europa editor, Stephanie Price, about the evolving UK cannabis industry and the opportunities for investment.
Sativa Group Plc (NEX:SATI) is the UK’s leading quoted CBD Wellness and medicinal cannabis group with five operating subsidiaries. Goodbody Botanicals provides CBD products online and to retail markets including pharmacies, wellness stores and grocers. Goodbody Wellness is a high-street retail brand with dedicated CBD Wellness stores providing a premium shopping experience to consumers. Tessellate Collective is a direct-selling network marketing platform servicing consumers at home. Phytovista laboratories provides independent testing of CBD products to both external customers and fellow Group businesses. Sativa Grow holds a Controlled Drug licence and cultivates cannabis plants to fulfill its partnership agreement with King’s College London to research the impact of cannabinoids on inflammation and respiratory conditions.